<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT933-14432</title>
	</head>
	<body>
		<main>
			<p>930714 FT  14 JUL 93 / International Company News: Ex-Glaxo chief joins small US drugs group MR ERNEST Mario, the former chief executive and vice-chairman of Glaxo, who left in March after a boardroom bust-up at Europe's largest pharmaceuticals company, has resurfaced in the pharmaceuticals industry. Alza Corporation, a small specialist drug delivery system company based in Palo Alto, California, announced yesterday Mr Mario would become co-chairman and chief executive from the beginning of August. The Californian company recorded sales last year of Dollars 250m and profits of Dollars 72.2m while Glaxo generated pre-tax profits Pounds 1.42bn on turnover of Pounds 4.09bn in 1992. Alza generates its income through royalty payments from pharmaceuticals groups using its technologies. Mr Mario replaces Mr Martin Gerstel who announced this year he planned to resign to pursue non-corporate interests.</p>
		</main>
</body></html>
            